Information Journal Paper
APA:
CopyGERNA, G., LILLERI, D., & FURIONE, M.. (2011). MANAGEMENT OF HUMAN CYTOMEGALOVIRUS INFECTION IN TRANSPLANTATION: VALIDATION OF VIROLOGIC CUT-OFFS FOR PREEMPTIVE THERAPY AND IMMUNOLOGICAL CUT-OFFS FOR PROTECTION. THE NEW MICROBIOLOGICA, 34(3), 229-254. SID. https://sid.ir/paper/657445/en
Vancouver:
CopyGERNA G., LILLERI D., FURIONE M.. MANAGEMENT OF HUMAN CYTOMEGALOVIRUS INFECTION IN TRANSPLANTATION: VALIDATION OF VIROLOGIC CUT-OFFS FOR PREEMPTIVE THERAPY AND IMMUNOLOGICAL CUT-OFFS FOR PROTECTION. THE NEW MICROBIOLOGICA[Internet]. 2011;34(3):229-254. Available from: https://sid.ir/paper/657445/en
IEEE:
CopyG. GERNA, D. LILLERI, and M. FURIONE, “MANAGEMENT OF HUMAN CYTOMEGALOVIRUS INFECTION IN TRANSPLANTATION: VALIDATION OF VIROLOGIC CUT-OFFS FOR PREEMPTIVE THERAPY AND IMMUNOLOGICAL CUT-OFFS FOR PROTECTION,” THE NEW MICROBIOLOGICA, vol. 34, no. 3, pp. 229–254, 2011, [Online]. Available: https://sid.ir/paper/657445/en